TickerFactsScreenerDevelopers

Anebulo Pharmaceuticals, Inc. (ANEB) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2021: -$4.87M2022: -$5.44M2023: -$9.68M2024: -$8.09M2025: -$6.35M-$6.35M
2021Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$6.35M+21.5%
2024-$8.09M+16.4%
2023-$9.68M-78.1%
2022-$5.44M-11.6%
2021-$4.87M—